Artificial Tears Market Size, Share | Global Industry Report 2033

The new report published by The Business Research Company, titled "" Artificial Tears Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the artificial tears market size has grown strongly in recent years. It will grow from $3.32 billion in 2023 to $3.55 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The artificial tears market size is expected to see strong growth in the next few years. It will grow to $4.55 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13799&type=smp

Artificial Tears Demand Soars As Dry Eye Disease Prevalence Increases
The rising prevalence of dry eye disease is expected to propel the growth of the artificial tear market going forward. Dry eye disease is a condition where the eyes do not produce enough tears, or the tears are of poor quality, leading to irritation and discomfort. Artificial tears supplement natural tear production, providing lubrication and relief for dry eyes. For instance, in March 2022, according to a survey of 5,000 respondents by Macquarie University, an Australia-based public research university, among individuals aged 50 and above, 13% (15 out of 120) showed clinical signs of dry eye disease (DED), categorized as 8.2% mild, 2.5% moderate, and 1.6% severe. Additionally, in March 2022, according to Eyes On Eyecare, a US-based digital ophthalmology news provider, the use of prescription and in-office treatments for dry eye disease increased from 5.8% in 2021 to 7.56% in 2022, with prescription treatments like topical steroids rising significantly from 0.9% to 9.1% during the same period. Therefore, the rising prevalence of dry eye disease is driving the growth of the artificial tear market.

Revolutionizing Eye Care With HydroBoost and PureFlow Bottle Technology
Major companies operating in the artificial tears market are developing products incorporating technologies such as HydroBoost and PureFlow bottle technology to increase their profitability in the market. HydroBoost and PureFlow bottle technology in artificial tears refers to specialized formulations and dispensing mechanisms designed to enhance hydration and sterility in eye lubrication products. For instance, in April 2021, Alcon, a Switzerland-based pharma company, released Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops. It features HydroBoost Technology, which offers enhanced hydration and comfort for sensitive, dry eyes and is preservative-free to reduce irritation. The unique PureFlow bottle ensures a sterile, multi-dose formula, making it convenient for frequent use. These drops provide a comprehensive solution for dry eye management and are ideal for aqueous dry eye sufferers, frequent users, and post-surgical patients.

The artificial tears market covered in this report is segmented -

1) By Type: Glycerin Tears, Cellulose Tears, Oil-Based Emulsion Tears, Polyethylene Glycol-based Tears, Sodium Hyaluronate Based Artificial Tears, Propylene Glycol-based Tears
2) By Dosage: Suspensions, Solution, Ointment, Emulsion, Gel, Spray
3) By Indication: Dry Eye Syndrome, Allergies, Infections, UV And Blue Light Protection, Contact Lens Moisture Retention, Other Indications
4) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Ophthalmic Stores

Buy Now & Get Exclusive Discount on this Report, Checkout link @

https://www.thebusinessresearchcompany.com/Discount?id=13799&type=discount

Major companies operating in the artificial tears market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Abbott Laboratories, Otsuka Pharmaceutical Co. Ltd., Alcon, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy's Laboratories, Santen Pharmaceutical Co. Ltd., Lupin Limited, Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Thea Pharma Inc., OPTIMA pharma GmbH, Sentiss Pharma Pvt. Ltd., VISUfarma B.V., OASIS Medical Inc., Hilco Vision, Similasan Corporation, Eyevance Pharmaceuticals LLC, Nicox S.A., I-MED Pharma Inc., Velocity Pharma LLC

Contents of the report:
1. Executive Summary
2. Artificial Tears Market Report Structure
3. Artificial Tears Market Trends And Strategies
4. Artificial Tears Market - Macro Economic Scenario
5. Artificial Tears Market Size And Growth
…..
27. Artificial Tears Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/artificial-tears-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.